We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eurand Addresses Questions Regarding Zentase NDA
Eurand Addresses Questions Regarding Zentase NDA
February 2, 2009
Eurand is expecting FDA action late in the second quarter on its investigational pancreatic enzyme product Zentase, after the agency accepted its raw material supplier’s response to questions about the NDA.